# Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy

> **NCT02496260** · — · COMPLETED · sponsor: **Henry Ford Health System** · enrollment: 25 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Research Cardiac MRI
- **PROCEDURE:** Biomarkers

## Key facts

- **NCT ID:** NCT02496260
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02496260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02496260, "Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02496260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*